Seres Therapeutics, Inc. (MCRB) stock
MCRBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30
$1.33−0.11 (-7.64%)
Close on Nov 19, 2026Market cap $13.22MP/E –Yield –
Seres Therapeutics pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Seres Therapeutics's pe ratio was 11.5× on Apr 30, 2026, against 617.0× a year earlier.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Apr 30, 2026 | 11.5× | −13.7 |
| 2025 | Dec 31, 2025 | 25.2× | – |
See a number that looks wrong?